Cargando…
Saliva Liquid Biopsy for Point-of-Care Applications
Saliva is a non-invasive biofluid, which is easy to collect, transport, and store. Because of its accessibility and connection to systemic diseases, saliva is one of the best candidates for the advancement of point-of-care medicine, where individuals are able to easily monitor their health status by...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387045/ https://www.ncbi.nlm.nih.gov/pubmed/28443278 http://dx.doi.org/10.3389/fpubh.2017.00077 |
_version_ | 1782520866367602688 |
---|---|
author | Aro, Katri Wei, Fang Wong, David T. Tu, Michael |
author_facet | Aro, Katri Wei, Fang Wong, David T. Tu, Michael |
author_sort | Aro, Katri |
collection | PubMed |
description | Saliva is a non-invasive biofluid, which is easy to collect, transport, and store. Because of its accessibility and connection to systemic diseases, saliva is one of the best candidates for the advancement of point-of-care medicine, where individuals are able to easily monitor their health status by using portable convenient tools such as smartphones. There are a variety of scenarios with which saliva can be used: studies have been conducted on using saliva to measure stress hormones, enzyme levels, developmental disease biomarkers, and even cancer mutations. If validated biomarkers were combined with high-quality detection tools, saliva would open up a new frontier in high-quality healthcare, allowing physicians and patients to work together for real-time health monitoring and high-impact personalized preventative medicine. One of the most exciting emerging frontiers of saliva is liquid biopsy, which is a non-invasive means to assess the presence and characteristics of cancer in a patient. This article will review current basic knowledge of biomarkers, review their relation to different diseases and conditions, and explore liquid biopsy for point-of-care applications. |
format | Online Article Text |
id | pubmed-5387045 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-53870452017-04-25 Saliva Liquid Biopsy for Point-of-Care Applications Aro, Katri Wei, Fang Wong, David T. Tu, Michael Front Public Health Public Health Saliva is a non-invasive biofluid, which is easy to collect, transport, and store. Because of its accessibility and connection to systemic diseases, saliva is one of the best candidates for the advancement of point-of-care medicine, where individuals are able to easily monitor their health status by using portable convenient tools such as smartphones. There are a variety of scenarios with which saliva can be used: studies have been conducted on using saliva to measure stress hormones, enzyme levels, developmental disease biomarkers, and even cancer mutations. If validated biomarkers were combined with high-quality detection tools, saliva would open up a new frontier in high-quality healthcare, allowing physicians and patients to work together for real-time health monitoring and high-impact personalized preventative medicine. One of the most exciting emerging frontiers of saliva is liquid biopsy, which is a non-invasive means to assess the presence and characteristics of cancer in a patient. This article will review current basic knowledge of biomarkers, review their relation to different diseases and conditions, and explore liquid biopsy for point-of-care applications. Frontiers Media S.A. 2017-04-11 /pmc/articles/PMC5387045/ /pubmed/28443278 http://dx.doi.org/10.3389/fpubh.2017.00077 Text en Copyright © 2017 Aro, Wei, Wong and Tu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Public Health Aro, Katri Wei, Fang Wong, David T. Tu, Michael Saliva Liquid Biopsy for Point-of-Care Applications |
title | Saliva Liquid Biopsy for Point-of-Care Applications |
title_full | Saliva Liquid Biopsy for Point-of-Care Applications |
title_fullStr | Saliva Liquid Biopsy for Point-of-Care Applications |
title_full_unstemmed | Saliva Liquid Biopsy for Point-of-Care Applications |
title_short | Saliva Liquid Biopsy for Point-of-Care Applications |
title_sort | saliva liquid biopsy for point-of-care applications |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387045/ https://www.ncbi.nlm.nih.gov/pubmed/28443278 http://dx.doi.org/10.3389/fpubh.2017.00077 |
work_keys_str_mv | AT arokatri salivaliquidbiopsyforpointofcareapplications AT weifang salivaliquidbiopsyforpointofcareapplications AT wongdavidt salivaliquidbiopsyforpointofcareapplications AT tumichael salivaliquidbiopsyforpointofcareapplications |